02/07/2012 Glaxo agrees to pay $3bn in fraud settlement
GlaxoSmithKline pleads guilty to £3bn fraud
Glaxo to Pay $3 Billion to Settle U.S. Charges
Drugmaker GlaxoSmithKline 'guilty of fraud'
GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States and agreed to pay a $3 billion settlement. It was the largest health-care fraud case to date in that country and the largest settlement by a drug company.
Research areas and products
Recognition, philanthropy and social responsibility